APO Research
Talk to an analyst

APO RESEARCH · REPORT

Icosapent Ethyl Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Icosapent Ethyl Drugs Market Analysis and Forecast 2026-2032

29 December 2025200 pages

Choose your research edition.

Industry ResearchIcosapent Ethyl Drugs Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Icosapent Ethyl Drugs Industry Growth and Trends Forecast to 2032118 pages · $3,450 USDMarket StructureGlobal Icosapent Ethyl Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Icosapent Ethyl Drugs Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Icosapent Ethyl Drugs Market Analysis and Forecast 2026-2032200 pages · $4,950 USD

Market perspective

The global Icosapent Ethyl Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Icosapent Ethyl Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Icosapent Ethyl Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Icosapent Ethyl Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Icosapent Ethyl Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Icosapent Ethyl Drugs include Sichuan Gowell Pharmaceutical, Humanwell Puracap Pharmaceuticals, Qilu Pharmaceutical, Jiangsu Wangao Pharmaceutical, Chengdu Suncadia Medicine, Zydus, Woodward Pharma, Teva and Sun Pharma, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Icosapent Ethyl Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Icosapent Ethyl Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Icosapent Ethyl Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Icosapent Ethyl Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Icosapent Ethyl Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Icosapent Ethyl Drugs sales, projected growth trends, production technology, application and end-user industry.

Icosapent Ethyl Drugs Segment by Company

Sichuan Gowell Pharmaceutical

Humanwell Puracap Pharmaceuticals

Qilu Pharmaceutical

Jiangsu Wangao Pharmaceutical

Chengdu Suncadia Medicine

Zydus

Woodward Pharma

Teva

Sun Pharma

Strides Pharma

PuraCap Pharmaceuticals

Mankind Pharma

Hikma

GLW Pharma

Dr. Reddy's Laboratories

Ascent Pharmaceuticals

Apotex

Amneal Pharmaceuticals

Amarin Pharmaceuticals

Icosapent Ethyl Drugs Segment by Type

Single Drug

Combination Drug

Icosapent Ethyl Drugs Segment by Application

Retail Pharmacy

Online Pharmacy

Hospital Pharmacy

Icosapent Ethyl Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Colombia

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Icosapent Ethyl Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Icosapent Ethyl Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Icosapent Ethyl Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Icosapent Ethyl Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Icosapent Ethyl Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Icosapent Ethyl Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Icosapent Ethyl Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Single Drug Major Manufacturers Table 3. Combination Drug Major Manufacturers Table 4. Global Icosapent Ethyl Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 5. Retail Pharmacy Major Manufacturers Table 6. Online Pharmacy Major Manufacturers Table 7. Hospital Pharmacy Major Manufacturers Table 8. Icosapent Ethyl Drugs Industry Trends Table 9. Icosapent Ethyl Drugs Industry Drivers Table 10. Icosapent Ethyl Drugs Industry Opportunities and Challenges Table 11. Icosapent Ethyl Drugs Industry Restraints Table 12. Global Icosapent Ethyl Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 13. Global Icosapent Ethyl Drugs Revenue by Region (2021-2026) & (US$ Million) Table 14. Global Icosapent Ethyl Drugs Revenue by Region (2027-2032) & (US$ Million) Table 15. Global Icosapent Ethyl Drugs Revenue Market Share by Region (2021-2026) Table 16. Global Icosapent Ethyl Drugs Revenue Market Share by Region (2027-2032) Table 17. Global Icosapent Ethyl Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (K Units) Table 18. Global Icosapent Ethyl Drugs Sales by Region (2021-2026) & (K Units) Table 19. Global Icosapent Ethyl Drugs Sales by Region (2027-2032) & (K Units) Table 20. Global Icosapent Ethyl Drugs Sales Market Share by Region (2021-2026) Table 21. Global Icosapent Ethyl Drugs Sales Market Share by Region (2027-2032) Table 22. Global Icosapent Ethyl Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 23. Global Icosapent Ethyl Drugs Revenue Market Share by Manufacturers (2021-2026) Table 24. Global Icosapent Ethyl Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Icosapent Ethyl Drugs Sales Market Share by Manufacturers (2021-2026) Table 26. Global Icosapent Ethyl Drugs Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 27. Global Icosapent Ethyl Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 28. Global Icosapent Ethyl Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 29. Global Icosapent Ethyl Drugs Manufacturers, Product Type & Application Table 30. Global Icosapent Ethyl Drugs Manufacturers' Establishment Date Table 31. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 32. Global Icosapent Ethyl Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 33. Global Icosapent Ethyl Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 34. Global Icosapent Ethyl Drugs Revenue by Type (2021-2026) & (US$ Million) Table 35. Global Icosapent Ethyl Drugs Revenue by Type (2027-2032) & (US$ Million) Table 36. Global Icosapent Ethyl Drugs Revenue Market Share by Type (2021-2026) Table 37. Global Icosapent Ethyl Drugs Revenue Market Share by Type (2027-2032) Table 38. Global Icosapent Ethyl Drugs Sales by Type 2021 VS 2025 VS 2032 (K Units) Table 39. Global Icosapent Ethyl Drugs Sales by Type (2021-2026) & (K Units) Table 40. Global Icosapent Ethyl Drugs Sales by Type (2027-2032) & (K Units) Table 41. Global Icosapent Ethyl Drugs Sales Market Share by Type (2021-2026) Table 42. Global Icosapent Ethyl Drugs Sales Market Share by Type (2027-2032) Table 43. Global Icosapent Ethyl Drugs Price by Type (2021-2026) & (US$/Unit) Table 44. Global Icosapent Ethyl Drugs Price by Type (2027-2032) & (US$/Unit) Table 45. Global Icosapent Ethyl Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 46. Global Icosapent Ethyl Drugs Revenue by Application (2021-2026) & (US$ Million) Table 47. Global Icosapent Ethyl Drugs Revenue by Application (2027-2032) & (US$ Million) Table 48. Global Icosapent Ethyl Drugs Revenue Market Share by Application (2021-2026) Table 49. Global Icosapent Ethyl Drugs Revenue Market Share by Application (2027-2032) Table 50. Global Icosapent Ethyl Drugs Sales by Application 2021 VS 2025 VS 2032 (K Units) Table 51. Global Icosapent Ethyl Drugs Sales by Application (2021-2026) & (K Units) Table 52. Global Icosapent Ethyl Drugs Sales by Application (2027-2032) & (K Units) Table 53. Global Icosapent Ethyl Drugs Sales Market Share by Application (2021-2026) Table 54. Global Icosapent Ethyl Drugs Sales Market Share by Application (2027-2032) Table 55. Global Icosapent Ethyl Drugs Price by Application (2021-2026) & (US$/Unit) Table 56. Global Icosapent Ethyl Drugs Price by Application (2027-2032) & (US$/Unit) Table 57. Sichuan Gowell Pharmaceutical Company Information Table 58. Sichuan Gowell Pharmaceutical Business Overview Table 59. Sichuan Gowell Pharmaceutical Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 60. Sichuan Gowell Pharmaceutical Icosapent Ethyl Drugs Product Portfolio Table 61. Sichuan Gowell Pharmaceutical Recent Development Table 62. Humanwell Puracap Pharmaceuticals Company Information Table 63. Humanwell Puracap Pharmaceuticals Business Overview Table 64. Humanwell Puracap Pharmaceuticals Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 65. Humanwell Puracap Pharmaceuticals Icosapent Ethyl Drugs Product Portfolio Table 66. Humanwell Puracap Pharmaceuticals Recent Development Table 67. Qilu Pharmaceutical Company Information Table 68. Qilu Pharmaceutical Business Overview Table 69. Qilu Pharmaceutical Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 70. Qilu Pharmaceutical Icosapent Ethyl Drugs Product Portfolio Table 71. Qilu Pharmaceutical Recent Development Table 72. Jiangsu Wangao Pharmaceutical Company Information Table 73. Jiangsu Wangao Pharmaceutical Business Overview Table 74. Jiangsu Wangao Pharmaceutical Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 75. Jiangsu Wangao Pharmaceutical Icosapent Ethyl Drugs Product Portfolio Table 76. Jiangsu Wangao Pharmaceutical Recent Development Table 77. Chengdu Suncadia Medicine Company Information Table 78. Chengdu Suncadia Medicine Business Overview Table 79. Chengdu Suncadia Medicine Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 80. Chengdu Suncadia Medicine Icosapent Ethyl Drugs Product Portfolio Table 81. Chengdu Suncadia Medicine Recent Development Table 82. Zydus Company Information Table 83. Zydus Business Overview Table 84. Zydus Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 85. Zydus Icosapent Ethyl Drugs Product Portfolio Table 86. Zydus Recent Development Table 87. Woodward Pharma Company Information Table 88. Woodward Pharma Business Overview Table 89. Woodward Pharma Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 90. Woodward Pharma Icosapent Ethyl Drugs Product Portfolio Table 91. Woodward Pharma Recent Development Table 92. Teva Company Information Table 93. Teva Business Overview Table 94. Teva Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 95. Teva Icosapent Ethyl Drugs Product Portfolio Table 96. Teva Recent Development Table 97. Sun Pharma Company Information Table 98. Sun Pharma Business Overview Table 99. Sun Pharma Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 100. Sun Pharma Icosapent Ethyl Drugs Product Portfolio Table 101. Sun Pharma Recent Development Table 102. Strides Pharma Company Information Table 103. Strides Pharma Business Overview Table 104. Strides Pharma Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 105. Strides Pharma Icosapent Ethyl Drugs Product Portfolio Table 106. Strides Pharma Recent Development Table 107. PuraCap Pharmaceuticals Company Information Table 108. PuraCap Pharmaceuticals Business Overview Table 109. PuraCap Pharmaceuticals Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 110. PuraCap Pharmaceuticals Icosapent Ethyl Drugs Product Portfolio Table 111. PuraCap Pharmaceuticals Recent Development Table 112. Mankind Pharma Company Information Table 113. Mankind Pharma Business Overview Table 114. Mankind Pharma Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 115. Mankind Pharma Icosapent Ethyl Drugs Product Portfolio Table 116. Mankind Pharma Recent Development Table 117. Hikma Company Information Table 118. Hikma Business Overview Table 119. Hikma Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 120. Hikma Icosapent Ethyl Drugs Product Portfolio Table 121. Hikma Recent Development Table 122. GLW Pharma Company Information Table 123. GLW Pharma Business Overview Table 124. GLW Pharma Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 125. GLW Pharma Icosapent Ethyl Drugs Product Portfolio Table 126. GLW Pharma Recent Development Table 127. Dr. Reddy's Laboratories Company Information Table 128. Dr. Reddy's Laboratories Business Overview Table 129. Dr. Reddy's Laboratories Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 130. Dr. Reddy's Laboratories Icosapent Ethyl Drugs Product Portfolio Table 131. Dr. Reddy's Laboratories Recent Development Table 132. Ascent Pharmaceuticals Company Information Table 133. Ascent Pharmaceuticals Business Overview Table 134. Ascent Pharmaceuticals Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 135. Ascent Pharmaceuticals Icosapent Ethyl Drugs Product Portfolio Table 136. Ascent Pharmaceuticals Recent Development Table 137. Apotex Company Information Table 138. Apotex Business Overview Table 139. Apotex Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 140. Apotex Icosapent Ethyl Drugs Product Portfolio Table 141. Apotex Recent Development Table 142. Amneal Pharmaceuticals Company Information Table 143. Amneal Pharmaceuticals Business Overview Table 144. Amneal Pharmaceuticals Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 145. Amneal Pharmaceuticals Icosapent Ethyl Drugs Product Portfolio Table 146. Amneal Pharmaceuticals Recent Development Table 147. Amarin Pharmaceuticals Company Information Table 148. Amarin Pharmaceuticals Business Overview Table 149. Amarin Pharmaceuticals Icosapent Ethyl Drugs Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 150. Amarin Pharmaceuticals Icosapent Ethyl Drugs Product Portfolio Table 151. Amarin Pharmaceuticals Recent Development Table 152. North America Icosapent Ethyl Drugs Revenue by Type (2021-2026) & (US$ Million) Table 153. North America Icosapent Ethyl Drugs Revenue by Type (2027-2032) & (US$ Million) Table 154. North America Icosapent Ethyl Drugs Sales by Type (2021-2026) & (K Units) Table 155. North America Icosapent Ethyl Drugs Sales by Type (2027-2032) & (K Units) Table 156. North America Icosapent Ethyl Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 157. North America Icosapent Ethyl Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 158. North America Icosapent Ethyl Drugs Revenue by Application (2021-2026) & (US$ Million) Table 159. North America Icosapent Ethyl Drugs Revenue by Application (2027-2032) & (US$ Million) Table 160. North America Icosapent Ethyl Drugs Sales by Application (2021-2026) & (K Units) Table 161. North America Icosapent Ethyl Drugs Sales by Application (2027-2032) & (K Units) Table 162. North America Icosapent Ethyl Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 163. North America Icosapent Ethyl Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 164. North America Icosapent Ethyl Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 165. North America Icosapent Ethyl Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 166. North America Icosapent Ethyl Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 167. North America Icosapent Ethyl Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 168. North America Icosapent Ethyl Drugs Sales by Country (2021-2026) & (K Units) Table 169. North America Icosapent Ethyl Drugs Sales by Country (2027-2032) & (K Units) Table 170. North America Icosapent Ethyl Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 171. North America Icosapent Ethyl Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 172. United States Icosapent Ethyl Drugs Revenue (2021-2032) & (US$ Million) Table 173. Canada Icosapent Ethyl Drugs Revenue (2021-2032) & (US$ Million) Table 174. Mexico Icosapent Ethyl Drugs Revenue (2021-2032) & (US$ Million) Table 175. Europe Icosapent Ethyl Drugs Revenue by Type (2021-2026) & (US$ Million) Table 176. Europe Icosapent Ethyl Drugs Revenue by Type (2027-2032) & (US$ Million) Table 177. Europe Icosapent Ethyl Drugs Sales by Type (2021-2026) & (K Units) Table 178. Europe Icosapent Ethyl Drugs Sales by Type (2027-2032) & (K Units) Table 179. Europe Icosapent Ethyl Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 180. Europe Icosapent Ethyl Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 181. Europe Icosapent Ethyl Drugs Revenue by Application (2021-2026) & (US$ Million) Table 182. Europe Icosapent Ethyl Drugs Revenue by Application (2027-2032) & (US$ Million) Table 183. Europe Icosapent Ethyl Drugs Sales by Application (2021-2026) & (K Units) Table 184. Europe Icosapent Ethyl Drugs Sales by Application (2027-2032) & (K Units) Table 185. Europe Icosapent Ethyl Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 186. Europe Icosapent Ethyl Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 187. Europe Icosapent Ethyl Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 188. Europe Icosapent Ethyl Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 189. Europe Icosapent Ethyl Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 190. Europe Icosapent Ethyl Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 191. Europe Icosapent Ethyl Drugs Sales by Country (2021-2026) & (K Units) Table 192. Europe Icosapent Ethyl Drugs Sales by Country (2027-2032) & (K Units) Table 193. Europe Icosapent Ethyl Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 194. Europe Icosapent Ethyl Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 195. Germany Icosapent Ethyl Drugs Revenue (2021-2032) & (US$ Million) Table 196. France Icosapent Ethyl Drugs Revenue (2021-2032) & (US$ Million) Table 197. U.K. Icosapent Ethyl Drugs Revenue (2021-2032) & (US$ Million) Table 198. Italy Icosapent Ethyl Drugs Revenue (2021-2032) & (US$ Million) Table 199. Russia Icosapent Ethyl Drugs Revenue (2021-2032) & (US$ Million) Table 200. Spain Icosapent Ethyl Drugs Revenue (2021-2032) & (US$ Million) Table 201. Netherlands Icosapent Ethyl Drugs Revenue (2021-2032) & (US$ Million) Table 202. Switzerland Icosapent Ethyl Drugs Revenue (2021-2032) & (US$ Million) Table 203. Sweden Icosapent Ethyl Drugs Revenue (2021-2032) & (US$ Million) Table 204. Poland Icosapent Ethyl Drugs Revenue (2021-2032) & (US$ Million) Table 205. China Icosapent Ethyl Drugs Revenue by Type (2021-2026) & (US$ Million) Table 206. China Icosapent Ethyl Drugs Revenue by Type (2027-2032) & (US$ Million) Table 207. China Icosapent Ethyl Drugs Sales by Type (2021-2026) & (K Units) Table 208. China Icosapent Ethyl Drugs Sales by Type (2027-2032) & (K Units) Table 209. China Icosapent Ethyl Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 210. China Icosapent Ethyl Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 211. China Icosapent Ethyl Drugs Revenue by Application (2021-2026) & (US$ Million) Table 212. China Icosapent Ethyl Drugs Revenue by Application (2027-2032) & (US$ Million) Table 213. China Icosapent Ethyl Drugs Sales by Application (2021-2026) & (K Units) Table 214. China Icosapent Ethyl Drugs Sales by Application (2027-2032) & (K Units) Table 215. China Icosapent Ethyl Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 216. China Icosapent Ethyl Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 217. Asia Icosapent Ethyl Drugs Revenue by Type (2021-2026) & (US$ Million) Table 218. Asia Icosapent Ethyl Drugs Revenue by Type (2027-2032) & (US$ Million) Table 219. Asia Icosapent Ethyl Drugs Sales by Type (2021-2026) & (K Units) Table 220. Asia Icosapent Ethyl Drugs Sales by Type (2027-2032) & (K Units) Table 221. Asia Icosapent Ethyl Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 222. Asia Icosapent Ethyl Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 223. Asia Icosapent Ethyl Drugs Revenue by Application (2021-2026) & (US$ Million) Table 224. Asia Icosapent Ethyl Drugs Revenue by Application (2027-2032) & (US$ Million) Table 225. Asia Icosapent Ethyl Drugs Sales by Application (2021-2026) & (K Units) Table 226. Asia Icosapent Ethyl Drugs Sales by Application (2027-2032) & (K Units) Table 227. Asia Icosapent Ethyl Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 228. Asia Icosapent Ethyl Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 229. Asia Icosapent Ethyl Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 230. Asia Icosapent Ethyl Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 231. Asia Icosapent Ethyl Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 232. Asia Icosapent Ethyl Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 233. Asia Icosapent Ethyl Drugs Sales by Country (2021-2026) & (K Units) Table 234. Asia Icosapent Ethyl Drugs Sales by Country (2027-2032) & (K Units) Table 235. Asia Icosapent Ethyl Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 236. Asia Icosapent Ethyl Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 237. Japan Icosapent Ethyl Drugs Revenue (2021-2032) & (US$ Million) Table 238. South Korea Icosapent Ethyl Drugs Revenue (2021-2032) & (US$ Million) Table 239. India Icosapent Ethyl Drugs Revenue (2021-2032) & (US$ Million) Table 240. Australia Icosapent Ethyl Drugs Revenue (2021-2032) & (US$ Million) Table 241. Taiwan Icosapent Ethyl Drugs Revenue (2021-2032) & (US$ Million) Table 242. Southeast Asia Icosapent Ethyl Drugs Revenue (2021-2032) & (US$ Million) Table 243. SAMEA Icosapent Ethyl Drugs Revenue by Type (2021-2026) & (US$ Million) Table 244. SAMEA Icosapent Ethyl Drugs Revenue by Type (2027-2032) & (US$ Million) Table 245. SAMEA Icosapent Ethyl Drugs Sales by Type (2021-2026) & (K Units) Table 246. SAMEA Icosapent Ethyl Drugs Sales by Type (2027-2032) & (K Units) Table 247. SAMEA Icosapent Ethyl Drugs Sales Price by Type (2021-2026) & (US$/Unit) Table 248. SAMEA Icosapent Ethyl Drugs Sales Price by Type (2027-2032) & (US$/Unit) Table 249. SAMEA Icosapent Ethyl Drugs Revenue by Application (2021-2026) & (US$ Million) Table 250. SAMEA Icosapent Ethyl Drugs Revenue by Application (2027-2032) & (US$ Million) Table 251. SAMEA Icosapent Ethyl Drugs Sales by Application (2021-2026) & (K Units) Table 252. SAMEA Icosapent Ethyl Drugs Sales by Application (2027-2032) & (K Units) Table 253. SAMEA Icosapent Ethyl Drugs Sales Price by Application (2021-2026) & (US$/Unit) Table 254. SAMEA Icosapent Ethyl Drugs Sales Price by Application (2027-2032) & (US$/Unit) Table 255. SAMEA Icosapent Ethyl Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 256. SAMEA Icosapent Ethyl Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 257. SAMEA Icosapent Ethyl Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 258. SAMEA Icosapent Ethyl Drugs Sales by Country (2021 VS 2025 VS 2032) & (K Units) Table 259. SAMEA Icosapent Ethyl Drugs Sales by Country (2021-2026) & (K Units) Table 260. SAMEA Icosapent Ethyl Drugs Sales by Country (2027-2032) & (K Units) Table 261. SAMEA Icosapent Ethyl Drugs Sales Price by Country (2021-2026) & (US$/Unit) Table 262. SAMEA Icosapent Ethyl Drugs Sales Price by Country (2027-2032) & (US$/Unit) Table 263. Brazil Icosapent Ethyl Drugs Revenue (2021-2032) & (US$ Million) Table 264. Argentina Icosapent Ethyl Drugs Revenue (2021-2032) & (US$ Million) Table 265. Chile Icosapent Ethyl Drugs Revenue (2021-2032) & (US$ Million) Table 266. Colombia Icosapent Ethyl Drugs Revenue (2021-2032) & (US$ Million) Table 267. Peru Icosapent Ethyl Drugs Revenue (2021-2032) & (US$ Million) Table 268. Saudi Arabia Icosapent Ethyl Drugs Revenue (2021-2032) & (US$ Million) Table 269. Israel Icosapent Ethyl Drugs Revenue (2021-2032) & (US$ Million) Table 270. UAE Icosapent Ethyl Drugs Revenue (2021-2032) & (US$ Million) Table 271. Turkey Icosapent Ethyl Drugs Revenue (2021-2032) & (US$ Million) Table 272. Iran Icosapent Ethyl Drugs Revenue (2021-2032) & (US$ Million) Table 273. Egypt Icosapent Ethyl Drugs Revenue (2021-2032) & (US$ Million) Table 274. Key Raw Materials Table 275. Raw Materials Key Suppliers Table 276. Icosapent Ethyl Drugs Distributors List Table 277. Icosapent Ethyl Drugs Customers List Table 278. Research Programs/Design for This Report Table 279. Authors List of This Report Table 280. Secondary Sources Table 281. Primary Sources List of Figures Figure 1. Icosapent Ethyl Drugs Image Figure 2. Global Icosapent Ethyl Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Icosapent Ethyl Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Single Drug Image Figure 5. Combination Drug Image Figure 6. Global Icosapent Ethyl Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 7. Global Icosapent Ethyl Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 8. Retail Pharmacy Image Figure 9. Online Pharmacy Image Figure 10. Hospital Pharmacy Image Figure 11. Global Icosapent Ethyl Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 12. Global Icosapent Ethyl Drugs Revenue (2021-2032) & (US$ Million) Figure 13. Global Icosapent Ethyl Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 14. Global Icosapent Ethyl Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 15. Global Icosapent Ethyl Drugs Revenue Market Share by Region (2021-2032) Figure 16. Global Icosapent Ethyl Drugs Sales (2021-2032) & (K Units) Figure 17. Global Icosapent Ethyl Drugs Sales by Region: 2021 VS 2025 VS 2032 (K Units) Figure 18. Global Icosapent Ethyl Drugs Sales Market Share by Region (2021-2032) Figure 19. US & Canada & Mexico Icosapent Ethyl Drugs Sales YoY (2021-2032) & (K Units) Figure 20. Europe Icosapent Ethyl Drugs Sales YoY (2021-2032) & (K Units) Figure 21. China Icosapent Ethyl Drugs Sales YoY (2021-2032) & (K Units) Figure 22. Asia (Excluding China) Icosapent Ethyl Drugs Sales YoY (2021-2032) & (K Units) Figure 23. South America, Middle East and Africa Icosapent Ethyl Drugs Sales YoY (2021-2032) & (K Units) Figure 24. Global Icosapent Ethyl Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 25. Global Icosapent Ethyl Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 26. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 27. Global Icosapent Ethyl Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 28. Global Icosapent Ethyl Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 29. Global Icosapent Ethyl Drugs Revenue Market Share by Type (2021-2032) Figure 30. Global Icosapent Ethyl Drugs Sales by Type (2021 VS 2025 VS 2032) & (K Units) Figure 31. Global Icosapent Ethyl Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Icosapent Ethyl Drugs Sales Market Share by Type (2021-2032) Figure 33. Global Icosapent Ethyl Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 34. Global Icosapent Ethyl Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 35. Global Icosapent Ethyl Drugs Revenue Market Share by Application (2021-2032) Figure 36. Global Icosapent Ethyl Drugs Sales by Application (2021 VS 2025 VS 2032) & (K Units) Figure 37. Global Icosapent Ethyl Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Icosapent Ethyl Drugs Sales Market Share by Application (2021-2032) Figure 39. North America Icosapent Ethyl Drugs Revenue Share by Type (2021-2032) Figure 40. North America Icosapent Ethyl Drugs Sales Share by Type (2021-2032) Figure 41. North America Icosapent Ethyl Drugs Revenue Share by Application (2021-2032) Figure 42. North America Icosapent Ethyl Drugs Sales Share by Application (2021-2032) Figure 43. North America Icosapent Ethyl Drugs Revenue Share by Country (2021-2032) Figure 44. North America Icosapent Ethyl Drugs Sales Share by Country (2021-2032) Figure 45. Europe Icosapent Ethyl Drugs Revenue Share by Type (2021-2032) Figure 46. Europe Icosapent Ethyl Drugs Sales Share by Type (2021-2032) Figure 47. Europe Icosapent Ethyl Drugs Revenue Share by Application (2021-2032) Figure 48. Europe Icosapent Ethyl Drugs Sales Share by Application (2021-2032) Figure 49. Europe Icosapent Ethyl Drugs Revenue Share by Country (2021-2032) Figure 50. Europe Icosapent Ethyl Drugs Sales Share by Country (2021-2032) Figure 51. China Icosapent Ethyl Drugs Revenue Share by Type (2021-2032) Figure 52. China Icosapent Ethyl Drugs Sales Share by Type (2021-2032) Figure 53. China Icosapent Ethyl Drugs Revenue Share by Application (2021-2032) Figure 54. China Icosapent Ethyl Drugs Sales Share by Application (2021-2032) Figure 55. Asia Icosapent Ethyl Drugs Revenue Share by Type (2021-2032) Figure 56. Asia Icosapent Ethyl Drugs Sales Share by Type (2021-2032) Figure 57. Asia Icosapent Ethyl Drugs Revenue Share by Application (2021-2032) Figure 58. Asia Icosapent Ethyl Drugs Sales Share by Application (2021-2032) Figure 59. Asia Icosapent Ethyl Drugs Revenue Share by Country (2021-2032) Figure 60. Asia Icosapent Ethyl Drugs Sales Share by Country (2021-2032) Figure 61. SAMEA Icosapent Ethyl Drugs Revenue Share by Type (2021-2032) Figure 62. SAMEA Icosapent Ethyl Drugs Sales Share by Type (2021-2032) Figure 63. SAMEA Icosapent Ethyl Drugs Revenue Share by Application (2021-2032) Figure 64. SAMEA Icosapent Ethyl Drugs Sales Share by Application (2021-2032) Figure 65. SAMEA Icosapent Ethyl Drugs Revenue Share by Country (2021-2032) Figure 66. SAMEA Icosapent Ethyl Drugs Sales Share by Country (2021-2032) Figure 67. Icosapent Ethyl Drugs Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Icosapent Ethyl Drugs Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • Single Drug
  • Combination Drug
Applications
  • Retail Pharmacy
  • Online Pharmacy
  • Hospital Pharmacy
Companies covered
  • Sichuan Gowell Pharmaceutical
  • Humanwell Puracap Pharmaceuticals
  • Qilu Pharmaceutical
  • Jiangsu Wangao Pharmaceutical
  • Chengdu Suncadia Medicine
  • Zydus
  • Woodward Pharma
  • Teva
  • Sun Pharma
  • Strides Pharma
  • PuraCap Pharmaceuticals
  • Mankind Pharma
  • Hikma
  • GLW Pharma
  • Dr. Reddy's Laboratories
  • Ascent Pharmaceuticals
  • Apotex
  • Amneal Pharmaceuticals
  • Amarin Pharmaceuticals

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Icosapent Ethyl Drugs Market by Type
  3. 1.2.1 Global Icosapent Ethyl Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Single Drug
  5. 1.2.3 Combination Drug
  6. 1.3 Icosapent Ethyl Drugs Market by Application
  7. 1.3.1 Global Icosapent Ethyl Drugs Market Size by Application, 2021 VS 2025 VS 2032
  8. 1.3.2 Retail Pharmacy
  9. 1.3.3 Online Pharmacy
  10. 1.3.4 Hospital Pharmacy
  11. 1.4 Assumptions and Limitations
  12. 1.5 Study Goals and Objectives
2 Icosapent Ethyl Drugs Market Dynamics
  1. 2.1 Icosapent Ethyl Drugs Industry Trends
  2. 2.2 Icosapent Ethyl Drugs Industry Drivers
  3. 2.3 Icosapent Ethyl Drugs Industry Opportunities and Challenges
  4. 2.4 Icosapent Ethyl Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Icosapent Ethyl Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Icosapent Ethyl Drugs Revenue by Region
  3. 3.2.1 Global Icosapent Ethyl Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Icosapent Ethyl Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global Icosapent Ethyl Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global Icosapent Ethyl Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Icosapent Ethyl Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Icosapent Ethyl Drugs Sales by Region
  9. 3.4.1 Global Icosapent Ethyl Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Icosapent Ethyl Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global Icosapent Ethyl Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global Icosapent Ethyl Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Icosapent Ethyl Drugs Revenue by Manufacturers
  2. 4.1.1 Global Icosapent Ethyl Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Icosapent Ethyl Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Icosapent Ethyl Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Icosapent Ethyl Drugs Sales by Manufacturers
  6. 4.2.1 Global Icosapent Ethyl Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Icosapent Ethyl Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Icosapent Ethyl Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Icosapent Ethyl Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Icosapent Ethyl Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Icosapent Ethyl Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Icosapent Ethyl Drugs Manufacturers, Product Type & Application
  13. 4.7 Global Icosapent Ethyl Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Icosapent Ethyl Drugs Market CR5 and HHI
  16. 4.8.2 2025 Icosapent Ethyl Drugs Tier 1, Tier 2, and Tier 3
5 Icosapent Ethyl Drugs Market by Type
  1. 5.1 Global Icosapent Ethyl Drugs Revenue by Type
  2. 5.1.1 Global Icosapent Ethyl Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Icosapent Ethyl Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Icosapent Ethyl Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Icosapent Ethyl Drugs Sales by Type
  6. 5.2.1 Global Icosapent Ethyl Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Icosapent Ethyl Drugs Sales by Type (2021-2032) & (K Units)
  8. 5.2.3 Global Icosapent Ethyl Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global Icosapent Ethyl Drugs Price by Type
6 Icosapent Ethyl Drugs Market by Application
  1. 6.1 Global Icosapent Ethyl Drugs Revenue by Application
  2. 6.1.1 Global Icosapent Ethyl Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Icosapent Ethyl Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Icosapent Ethyl Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Icosapent Ethyl Drugs Sales by Application
  6. 6.2.1 Global Icosapent Ethyl Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Icosapent Ethyl Drugs Sales by Application (2021-2032) & (K Units)
  8. 6.2.3 Global Icosapent Ethyl Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global Icosapent Ethyl Drugs Price by Application
7 Company Profiles
  1. 7.1 Sichuan Gowell Pharmaceutical
  2. 7.1.1 Sichuan Gowell Pharmaceutical Company Information
  3. 7.1.2 Sichuan Gowell Pharmaceutical Business Overview
  4. 7.1.3 Sichuan Gowell Pharmaceutical Icosapent Ethyl Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Sichuan Gowell Pharmaceutical Icosapent Ethyl Drugs Product Portfolio
  6. 7.1.5 Sichuan Gowell Pharmaceutical Recent Developments
  7. 7.2 Humanwell Puracap Pharmaceuticals
  8. 7.2.1 Humanwell Puracap Pharmaceuticals Company Information
  9. 7.2.2 Humanwell Puracap Pharmaceuticals Business Overview
  10. 7.2.3 Humanwell Puracap Pharmaceuticals Icosapent Ethyl Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Humanwell Puracap Pharmaceuticals Icosapent Ethyl Drugs Product Portfolio
  12. 7.2.5 Humanwell Puracap Pharmaceuticals Recent Developments
  13. 7.3 Qilu Pharmaceutical
  14. 7.3.1 Qilu Pharmaceutical Company Information
  15. 7.3.2 Qilu Pharmaceutical Business Overview
  16. 7.3.3 Qilu Pharmaceutical Icosapent Ethyl Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Qilu Pharmaceutical Icosapent Ethyl Drugs Product Portfolio
  18. 7.3.5 Qilu Pharmaceutical Recent Developments
  19. 7.4 Jiangsu Wangao Pharmaceutical
  20. 7.4.1 Jiangsu Wangao Pharmaceutical Company Information
  21. 7.4.2 Jiangsu Wangao Pharmaceutical Business Overview
  22. 7.4.3 Jiangsu Wangao Pharmaceutical Icosapent Ethyl Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Jiangsu Wangao Pharmaceutical Icosapent Ethyl Drugs Product Portfolio
  24. 7.4.5 Jiangsu Wangao Pharmaceutical Recent Developments
  25. 7.5 Chengdu Suncadia Medicine
  26. 7.5.1 Chengdu Suncadia Medicine Company Information
  27. 7.5.2 Chengdu Suncadia Medicine Business Overview
  28. 7.5.3 Chengdu Suncadia Medicine Icosapent Ethyl Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Chengdu Suncadia Medicine Icosapent Ethyl Drugs Product Portfolio
  30. 7.5.5 Chengdu Suncadia Medicine Recent Developments
  31. 7.6 Zydus
  32. 7.6.1 Zydus Company Information
  33. 7.6.2 Zydus Business Overview
  34. 7.6.3 Zydus Icosapent Ethyl Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Zydus Icosapent Ethyl Drugs Product Portfolio
  36. 7.6.5 Zydus Recent Developments
  37. 7.7 Woodward Pharma
  38. 7.7.1 Woodward Pharma Company Information
  39. 7.7.2 Woodward Pharma Business Overview
  40. 7.7.3 Woodward Pharma Icosapent Ethyl Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Woodward Pharma Icosapent Ethyl Drugs Product Portfolio
  42. 7.7.5 Woodward Pharma Recent Developments
  43. 7.8 Teva
  44. 7.8.1 Teva Company Information
  45. 7.8.2 Teva Business Overview
  46. 7.8.3 Teva Icosapent Ethyl Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Teva Icosapent Ethyl Drugs Product Portfolio
  48. 7.8.5 Teva Recent Developments
  49. 7.9 Sun Pharma
  50. 7.9.1 Sun Pharma Company Information
  51. 7.9.2 Sun Pharma Business Overview
  52. 7.9.3 Sun Pharma Icosapent Ethyl Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Sun Pharma Icosapent Ethyl Drugs Product Portfolio
  54. 7.9.5 Sun Pharma Recent Developments
  55. 7.10 Strides Pharma
  56. 7.10.1 Strides Pharma Company Information
  57. 7.10.2 Strides Pharma Business Overview
  58. 7.10.3 Strides Pharma Icosapent Ethyl Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Strides Pharma Icosapent Ethyl Drugs Product Portfolio
  60. 7.10.5 Strides Pharma Recent Developments
  61. 7.11 PuraCap Pharmaceuticals
  62. 7.11.1 PuraCap Pharmaceuticals Company Information
  63. 7.11.2 PuraCap Pharmaceuticals Business Overview
  64. 7.11.3 PuraCap Pharmaceuticals Icosapent Ethyl Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 PuraCap Pharmaceuticals Icosapent Ethyl Drugs Product Portfolio
  66. 7.11.5 PuraCap Pharmaceuticals Recent Developments
  67. 7.12 Mankind Pharma
  68. 7.12.1 Mankind Pharma Company Information
  69. 7.12.2 Mankind Pharma Business Overview
  70. 7.12.3 Mankind Pharma Icosapent Ethyl Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Mankind Pharma Icosapent Ethyl Drugs Product Portfolio
  72. 7.12.5 Mankind Pharma Recent Developments
  73. 7.13 Hikma
  74. 7.13.1 Hikma Company Information
  75. 7.13.2 Hikma Business Overview
  76. 7.13.3 Hikma Icosapent Ethyl Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Hikma Icosapent Ethyl Drugs Product Portfolio
  78. 7.13.5 Hikma Recent Developments
  79. 7.14 GLW Pharma
  80. 7.14.1 GLW Pharma Company Information
  81. 7.14.2 GLW Pharma Business Overview
  82. 7.14.3 GLW Pharma Icosapent Ethyl Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 GLW Pharma Icosapent Ethyl Drugs Product Portfolio
  84. 7.14.5 GLW Pharma Recent Developments
  85. 7.15 Dr. Reddy's Laboratories
  86. 7.15.1 Dr. Reddy's Laboratories Company Information
  87. 7.15.2 Dr. Reddy's Laboratories Business Overview
  88. 7.15.3 Dr. Reddy's Laboratories Icosapent Ethyl Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Dr. Reddy's Laboratories Icosapent Ethyl Drugs Product Portfolio
  90. 7.15.5 Dr. Reddy's Laboratories Recent Developments
  91. 7.16 Ascent Pharmaceuticals
  92. 7.16.1 Ascent Pharmaceuticals Company Information
  93. 7.16.2 Ascent Pharmaceuticals Business Overview
  94. 7.16.3 Ascent Pharmaceuticals Icosapent Ethyl Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Ascent Pharmaceuticals Icosapent Ethyl Drugs Product Portfolio
  96. 7.16.5 Ascent Pharmaceuticals Recent Developments
  97. 7.17 Apotex
  98. 7.17.1 Apotex Company Information
  99. 7.17.2 Apotex Business Overview
  100. 7.17.3 Apotex Icosapent Ethyl Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Apotex Icosapent Ethyl Drugs Product Portfolio
  102. 7.17.5 Apotex Recent Developments
  103. 7.18 Amneal Pharmaceuticals
  104. 7.18.1 Amneal Pharmaceuticals Company Information
  105. 7.18.2 Amneal Pharmaceuticals Business Overview
  106. 7.18.3 Amneal Pharmaceuticals Icosapent Ethyl Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  107. 7.18.4 Amneal Pharmaceuticals Icosapent Ethyl Drugs Product Portfolio
  108. 7.18.5 Amneal Pharmaceuticals Recent Developments
  109. 7.19 Amarin Pharmaceuticals
  110. 7.19.1 Amarin Pharmaceuticals Company Information
  111. 7.19.2 Amarin Pharmaceuticals Business Overview
  112. 7.19.3 Amarin Pharmaceuticals Icosapent Ethyl Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  113. 7.19.4 Amarin Pharmaceuticals Icosapent Ethyl Drugs Product Portfolio
  114. 7.19.5 Amarin Pharmaceuticals Recent Developments
8 North America
  1. 8.1 North America Icosapent Ethyl Drugs Market Size by Type
  2. 8.1.1 North America Icosapent Ethyl Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America Icosapent Ethyl Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America Icosapent Ethyl Drugs Price by Type (2021-2032)
  5. 8.2 North America Icosapent Ethyl Drugs Market Size by Application
  6. 8.2.1 North America Icosapent Ethyl Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America Icosapent Ethyl Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America Icosapent Ethyl Drugs Price by Application (2021-2032)
  9. 8.3 North America Icosapent Ethyl Drugs Market Size by Country
  10. 8.3.1 North America Icosapent Ethyl Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Icosapent Ethyl Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Icosapent Ethyl Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Icosapent Ethyl Drugs Market Size by Type
  2. 9.1.1 Europe Icosapent Ethyl Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe Icosapent Ethyl Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe Icosapent Ethyl Drugs Price by Type (2021-2032)
  5. 9.2 Europe Icosapent Ethyl Drugs Market Size by Application
  6. 9.2.1 Europe Icosapent Ethyl Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe Icosapent Ethyl Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe Icosapent Ethyl Drugs Price by Application (2021-2032)
  9. 9.3 Europe Icosapent Ethyl Drugs Market Size by Country
  10. 9.3.1 Europe Icosapent Ethyl Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Icosapent Ethyl Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Icosapent Ethyl Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Icosapent Ethyl Drugs Market Size by Type
  2. 10.1.1 China Icosapent Ethyl Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China Icosapent Ethyl Drugs Sales by Type (2021-2032)
  4. 10.1.3 China Icosapent Ethyl Drugs Price by Type (2021-2032)
  5. 10.2 China Icosapent Ethyl Drugs Market Size by Application
  6. 10.2.1 China Icosapent Ethyl Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China Icosapent Ethyl Drugs Sales by Application (2021-2032)
  8. 10.2.3 China Icosapent Ethyl Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Icosapent Ethyl Drugs Market Size by Type
  2. 11.1.1 Asia Icosapent Ethyl Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia Icosapent Ethyl Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia Icosapent Ethyl Drugs Price by Type (2021-2032)
  5. 11.2 Asia Icosapent Ethyl Drugs Market Size by Application
  6. 11.2.1 Asia Icosapent Ethyl Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia Icosapent Ethyl Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia Icosapent Ethyl Drugs Price by Application (2021-2032)
  9. 11.3 Asia Icosapent Ethyl Drugs Market Size by Country
  10. 11.3.1 Asia Icosapent Ethyl Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Icosapent Ethyl Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Icosapent Ethyl Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Icosapent Ethyl Drugs Market Size by Type
  2. 12.1.1 SAMEA Icosapent Ethyl Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Icosapent Ethyl Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Icosapent Ethyl Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA Icosapent Ethyl Drugs Market Size by Application
  6. 12.2.1 SAMEA Icosapent Ethyl Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Icosapent Ethyl Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Icosapent Ethyl Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA Icosapent Ethyl Drugs Market Size by Country
  10. 12.3.1 SAMEA Icosapent Ethyl Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Icosapent Ethyl Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Icosapent Ethyl Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Icosapent Ethyl Drugs Value Chain Analysis
  2. 13.1.1 Icosapent Ethyl Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Icosapent Ethyl Drugs Production Mode & Process
  6. 13.2 Icosapent Ethyl Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Icosapent Ethyl Drugs Distributors
  9. 13.2.3 Icosapent Ethyl Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst